CLINICAL_TRIALS
trial_result
· 2018-06-11
Clinical Trial Update: Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) [Phase 3]
Summary
Phase 3 trial evaluating stem cell transplant with lenalidomide maintenance for multiple myeloma has completed; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2018-06-11